Trial Profile
Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 07 Mar 2022
Price :
$35
*
At a glance
- Drugs Droxidopa (Primary)
- Indications Fatigue; Parkinson's disease
- Focus Therapeutic Use
- 14 Feb 2022 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 11 Aug 2021 Planned initiation date changed from 1 Jul 2021 to 1 Dec 2021.
- 19 Apr 2021 Planned End Date changed from 1 Jan 2021 to 1 Jul 2023.